Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000118051 | SCV000152380 | uncertain significance | not provided | 2013-08-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000186656 | SCV000171187 | benign | not specified | 2014-02-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001085376 | SCV000767806 | likely benign | Epilepsy, progressive myoclonic, 1B | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000118051 | SCV000843385 | uncertain significance | not provided | 2018-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000186656 | SCV002725693 | likely benign | not specified | 2017-09-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003945056 | SCV004760998 | likely benign | PRICKLE1-related disorder | 2022-03-31 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |